Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. Issue 1 (December 2017) - Sellam, Jérémie; Rivière, Elodie; Courties, Alice; Rouzaire, Paul-Olivier; Tolusso, Barbara; Vital, Edward; Emery, Paul; Ferracioli, Gianfranco; Soubrier, Martin; Ly, Bineta; Chavez, Houria; Taoufik, Yassine; et al.